IMRX / Immuneering Corporation - Institutionellt ägande - Säljare

Immuneering Corporation
US ˙ NasdaqGM ˙ US45254E1073

Institutionellt ägande och fondägande - Säljare

Denna sida visar institutioner, fonder och större aktieägare som har minskat sina innehav eller stängt sina positioner under den senaste rapporteringsperioden. Röda rader indikerar stängda positioner. Klicka på länk-symbolen för att se hela transaktionshistoriken.

Uppgraderaför att låsa upp premiumdata.

Fil Datum Källa Investerare Typ Genomsnittligt pris
(beräknat)
Aktier Δ Aktier
(%)
Rapporterat
värde
(1000 USD)
Δ Värde
(%)
Portföljallokering
(%)
2025-08-14 13F Two Sigma Investments, Lp 18 553 −48,11 63 14,81
2025-08-26 NP QAAGZX - T. Rowe Price Health Sciences Portfolio This fund is a listed as child fund of Price T Rowe Associates Inc /md/ and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value 0 −100,00 0 −100,00
2025-08-13 13F Federated Hermes, Inc. 0 −100,00 0
2025-08-14 13F Price T Rowe Associates Inc /md/ 0 −100,00 0
2025-08-26 NP EQ ADVISORS TRUST - EQ/T. Rowe Price Health Sciences Portfolio Class IB 0 −100,00 0 −100,00
2025-05-14 13F JustInvest LLC 0 −100,00 0 −100,00
2025-05-14 13F Rockefeller Capital Management L.P. 0 −100,00 0 −100,00
2025-08-28 NP JAFMX - Health Sciences Trust NAV 0 −100,00 0 −100,00
2025-08-14 13F Engineers Gate Manager LP 0 −100,00 0 −100,00
2025-05-29 13F/A Legal & General Group Plc 0 −100,00 0 −100,00
2025-04-28 13F Vontobel Holding Ltd. 0 −100,00 0 −100,00
2025-08-14 13F UBS Group AG 5 073 −82,23 17 −60,47
2025-08-15 13F Morgan Stanley 201 094 −56,96 678 −4,65
2025-05-15 13F Point72 Asia (Singapore) Pte. Ltd. 0 −100,00 0 −100,00
2025-08-28 NP JAFEX - Total Stock Market Index Trust NAV 0 −100,00 0
2025-08-15 13F Tower Research Capital LLC (TRC) 2 984 −52,84 10 11,11
2025-04-28 NP CNCR - Loncar Cancer Immunotherapy ETF 54 838 −6,02 90 −25,62
2025-05-15 13F Man Group plc 0 −100,00 0 −100,00
2025-04-28 NP John Hancock Funds II - Health Sciences Fund Class NAV 20 374 −39,92 34 −52,86
2025-08-14 13F Jane Street Group, Llc 0 −100,00 0
2025-07-24 13F Us Bancorp \de\ 0 −100,00 0
2025-08-14 13F Bank Of America Corp /de/ 28 492 −1,25 96 123,26
2025-04-17 13F Exchange Traded Concepts, Llc 0 −100,00 0 −100,00
2025-06-12 13F/A Deutsche Bank Ag\ 0 −100,00 0 −100,00
2025-04-08 13F/A California State Teachers Retirement System 0 −100,00 0 −100,00
2025-08-13 13F Marshall Wace, Llp 573 864 −28,97 1 934 57,41
2025-07-28 13F Td Asset Management Inc 0 −100,00 0 −100,00
2025-05-15 13F/A Corsair Capital Management, L.p. 0 −100,00 0 −100,00
2025-08-14 13F Manufacturers Life Insurance Company, The 0 −100,00 0
2025-05-15 13F Tang Capital Management Llc 0 −100,00 0 −100,00
2025-08-26 NP PRHSX - T. Rowe Price Health Sciences Fund, Inc. This fund is a listed as child fund of Price T Rowe Associates Inc /md/ and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value 0 −100,00 0 −100,00
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista